It appears to me this is the FDA covering there backside so to speak and ensuring expert panel discuss older trial results.
Everything must be discussed.
FDA conclusion on safety and efficiency is the statement of what they are thinking pre meeting. Imo.
- Forums
- ASX - By Stock
- MSB
- FDA ODAC Meeting Material discussion analysis
MSB
mesoblast limited
Add to My Watchlist
4.15%
!
$2.31

FDA ODAC Meeting Material discussion analysis, page-165
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
-0.100(4.15%) |
Mkt cap ! $2.956B |
Open | High | Low | Value | Volume |
$2.33 | $2.35 | $2.15 | $30.94M | 13.57M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 75954 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 10350 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 75954 | 2.300 |
1 | 8580 | 2.290 |
2 | 10438 | 2.280 |
7 | 19928 | 2.270 |
3 | 9726 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 10350 | 2 |
2.340 | 56503 | 6 |
2.350 | 108804 | 14 |
2.360 | 31450 | 3 |
2.380 | 18175 | 4 |
Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |